全文获取类型
收费全文 | 9843篇 |
免费 | 911篇 |
国内免费 | 1篇 |
出版年
2023年 | 65篇 |
2022年 | 122篇 |
2021年 | 312篇 |
2020年 | 149篇 |
2019年 | 192篇 |
2018年 | 256篇 |
2017年 | 226篇 |
2016年 | 351篇 |
2015年 | 577篇 |
2014年 | 618篇 |
2013年 | 750篇 |
2012年 | 818篇 |
2011年 | 886篇 |
2010年 | 528篇 |
2009年 | 401篇 |
2008年 | 618篇 |
2007年 | 603篇 |
2006年 | 485篇 |
2005年 | 455篇 |
2004年 | 420篇 |
2003年 | 333篇 |
2002年 | 314篇 |
2001年 | 97篇 |
2000年 | 81篇 |
1999年 | 82篇 |
1998年 | 66篇 |
1997年 | 53篇 |
1996年 | 47篇 |
1995年 | 65篇 |
1994年 | 42篇 |
1993年 | 39篇 |
1992年 | 37篇 |
1991年 | 45篇 |
1990年 | 41篇 |
1989年 | 37篇 |
1988年 | 33篇 |
1987年 | 31篇 |
1986年 | 29篇 |
1985年 | 25篇 |
1984年 | 45篇 |
1983年 | 25篇 |
1982年 | 16篇 |
1981年 | 25篇 |
1980年 | 16篇 |
1978年 | 16篇 |
1977年 | 21篇 |
1976年 | 19篇 |
1975年 | 23篇 |
1974年 | 15篇 |
1973年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Rigorous extraction methods coupled with capillary gel electrophoresis (CGE) provide a basis for a nonradiolabel assay for quantitation of intact antisense drug and its numerous chain-shortened metabolites. As part of the validation of the CGE method, we compared the quantitation of unlabeled ISIS 3521 (ISI 641A) and its chain-shortened metabolites with total radioactivity of [(35)S]-ISIS 3521. ISIS 3521 was labeled on the fifth nucleotide linkage from the 5'-end with (35)S by well-established methods. Multiple tissues collected from rats after administration of [(35)S]-ISIS 3521 were assayed by both radiolabel (liquid scintillation spectroscopy) and CGE methods. The CGE method provided accurate quantitation of the drug and its metabolites in kidney cortex and liver tissues. The correlation between methods for multiple tissues over time was excellent with 88.5% of the measurements being statistically equivalent. These data suggest that CGE is an accurate means of quantitating oligonucleotide in tissue and that it compares favorably with traditional radiochemical techniques. Clearance half-lives for total measurable oligonucleotides were equivalent to clearance of total radioactivity in both liver and kidney with the longest clearance half-life associated with the kidney. 相似文献
2.
3.
Zhaolin Wang Cara Fraley Adam R. Mezo 《Bioorganic & medicinal chemistry letters》2013,23(5):1253-1256
The neonatal Fc receptor, FcRn, prolongs the half-life of IgG in the serum and represents a potential therapeutic target for the treatment of autoimmune disease. Small molecules that block the protein–protein interactions of human IgG–human FcRn may lower pathogenic autoantibodies and provide effective treatment. A novel class of quinoxalines has been discovered as antagonists of the IgG:FcRn protein–protein interaction through optimization of a hit derived from a virtual ligand-based screen. 相似文献
4.
5.
Plant and Soil - Cracks and biopores in compacted soil such as plough pans could aid deep rooting, mitigating constraints to seasonal upland use of paddy fields for rice production. This research... 相似文献
6.
7.
Hierarchy and monophyly 总被引:1,自引:0,他引:1
8.
Eliot C. Bush Anne E. Clark Chris M. DeBoever Lillian E. Haynes Sidra Hussain Singer Ma Matthew M. McDermott Adam M. Novak John S. Wentworth 《PloS one》2012,7(11)
A significant proportion of enzymes display cooperativity in binding ligand molecules, and such effects have an important impact on metabolic regulation. This is easiest to understand in the case of positive cooperativity. Sharp responses to changes in metabolite concentrations can allow organisms to better respond to environmental changes and maintain metabolic homeostasis. However, despite the fact that negative cooperativity is almost as common as positive, it has been harder to imagine what advantages it provides. Here we use computational models to explore the utility of negative cooperativity in one particular context: that of an inhibitor binding to an enzyme. We identify several factors which may contribute, and show that acting together they can make negative cooperativity advantageous. 相似文献
9.
A Adam J Damas P Franchimont 《Comptes rendus des séances de la Société de biologie et de ses filiales》1980,174(5):856-862
A radioimmunoassay for low molecular weight (LMW) human Kininogen has been carried out. The first step was to prepare LMW Kininogen from human plasma. The proposed method allowed to get chemically pure and biologically active LMW Kininogen. This preparation was used to induce antibody. Optimal conditions for labelling and incubation were determined. This method may be applied to the assay of Kininogen in human plasma. 相似文献
10.